We are live on ! Find out more
SRDX

Surmodics

Delisted

SRDX was delisted on the 18th of November, 2025.

125 hedge funds and large institutions have $255M invested in Surmodics in 2015 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 47 increasing their positions, 45 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

3% more funds holding

Funds holding: 121125 (+4)

4% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 45

7% less capital invested

Capital invested by funds: $274M → $255M (-$19.4M)

85% less call options, than puts

Call options by funds: $29K | Put options by funds: $198K

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
125
Holders Change
+4
Holders Change %
+3.31%
% of All Funds
3.48%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
12
Increased
47
Reduced
45
Closed
8
Calls
$29K
Puts
$198K
Net Calls
-$169K
Net Calls Change
-$31K

SRDX Hedge Fund Activity: Q3 2015 in Review

125 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q3 2015, worth a combined $255M — down 7.1% from $274M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new SRDX positions and 8 closed out — a net gain of 4 holders — while 47 added to existing stakes and 45 trimmed.

The largest buyer was Calvert Investment Management, opening a new position worth an estimated $4.72M. The largest seller was Wellington Management Group, cutting an estimated $2.76M.

  • 125 institutional investors held Surmodics (SRDX) as of Q3 2015, up from 121 in Q2 2015.
  • Funds reported $255M of Surmodics stock for Q3 2015, down 7.1% quarter-over-quarter.
  • 12 funds opened new Surmodics positions in Q3 2015 and 8 closed out, a net change of +4 holders.
  • The largest Surmodics buyer in Q3 2015 was Calvert Investment Management, an estimated $4.72M added.
  • The largest Surmodics seller in Q3 2015 was Wellington Management Group, an estimated $2.76M sold.

Based on aggregated 13F filings for Q3 2015.